Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy

Purpose: To compare the efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation with mitomycin C (MMC) versus trabeculectomy with MMC. Design: International, multicenter, retrospective interventional cohort study. Participants: Three hundred fifty-four...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schlenker, Matthew (VerfasserIn) , Hengerer, Fritz (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 7, 2017
In: Ophthalmology
Year: 2017, Jahrgang: 124, Heft: 11, Pages: 1579-1588
ISSN:1549-4713
DOI:10.1016/j.ophtha.2017.05.004
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.ophtha.2017.05.004
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0161642017304645
Volltext
Verfasserangaben:Matthew B. Schlenker, Husayn Gulamhusein, Ina Conrad-Hengerer, Alix Somers, Markus Lenzhofer, Ingeborg Stalmans, Herbert Reitsamer, Fritz H. Hengerer, Iqbal Ike K. Ahmed

MARC

LEADER 00000caa a2200000 c 4500
001 1574984756
003 DE-627
005 20240316100351.0
007 cr uuu---uuuuu
008 180511s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ophtha.2017.05.004  |2 doi 
035 |a (DE-627)1574984756 
035 |a (DE-576)504984756 
035 |a (DE-599)BSZ504984756 
035 |a (OCoLC)1341008321 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schlenker, Matthew  |e VerfasserIn  |0 (DE-588)1159405557  |0 (DE-627)1021626996  |0 (DE-576)504985116  |4 aut 
245 1 0 |a Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy  |c Matthew B. Schlenker, Husayn Gulamhusein, Ina Conrad-Hengerer, Alix Somers, Markus Lenzhofer, Ingeborg Stalmans, Herbert Reitsamer, Fritz H. Hengerer, Iqbal Ike K. Ahmed 
264 1 |c June 7, 2017 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.05.2018 
520 |a Purpose: To compare the efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation with mitomycin C (MMC) versus trabeculectomy with MMC. Design: International, multicenter, retrospective interventional cohort study. Participants: Three hundred fifty-four eyes of 293 patients (185 microstent and 169 trabeculectomy) with no prior incisional surgery. Methods: Consecutive eyes with uncontrolled glaucoma underwent microstent or trabeculectomy surgery from January 1, 2011 through July 31, 2015 at 4 academic ophthalmology centers: Toronto, Canada; Frankfurt, Germany; Salzburg, Austria; and Leuven, Belgium. Main Outcome Measures Primary outcome measure was hazard ratio (HR) of failure, with failure defined as 2 consecutive intraocular pressure (IOP) readings of <6 mmHg with vision loss or >17 mmHg without glaucoma medications (complete success) at least 1 month after surgery despite in-clinic interventions (including needling). Secondary outcome measures included IOP thresholds of 6 to 14 mmHg and 6 to 21 mmHg and same thresholds allowing for medications (qualified success), interventions, complications, and reoperations. Results: Baseline characteristics were similar, except more men (56% vs. 43%), younger patients (average, by 3 years), better preoperative visual acuity (22% vs. 32% with 0.4 logarithm of the minimum angle of resolution vision or worse), and more trabeculoplasty (52% vs. 30%) among microstent eyes. The adjusted HR of failure of the microstent relative to trabeculectomy was 1.2 (95% confidence interval [CI], 0.7-2.0) for complete success and 1.3 (95% CI, 0.6-2.8) for qualified success, and similar for other outcomes. Time to 25% failure was 11.2 months (95% CI, 6.9-16.1 months) and 10.6 months (95% CI, 6.8-16.2 months) for complete success and 30.3 months (95% CI, 19.0-∞ months) and 33.3 months (95% CI, 25.7-46.2 months) for qualified success. Overall, white ethnicity was associated with decreased risk of failure (adjusted HR, 0.49; 95% CI, 0.25-0.96), and diabetes was associated with increased risk of failure (adjusted HR, 4.21; 95% CI, 2.10-8.45). There were 117 and 165 distinct interventions: 43% and 31% underwent needling, respectively, and 50% of trabeculectomy eyes underwent laser suture lysis. There were 22 and 30 distinct complications, although most were transient. Ten percent and 5% underwent reoperation (P = 0.11). Conclusions: There was no detectable difference in risk of failure and safety profiles between standalone ab interno microstent with MMC and trabeculectomy with MMC. 
700 1 |a Hengerer, Fritz  |d 1970-  |e VerfasserIn  |0 (DE-588)12088142X  |0 (DE-627)705060470  |0 (DE-576)292429053  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmology  |d Amsterdam [u.a.] : Elsevier, 1978  |g 124(2017), 11, Seite 1579-1588  |h Online-Ressource  |w (DE-627)320526941  |w (DE-600)2015287-5  |w (DE-576)121465691  |x 1549-4713  |7 nnas  |a Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy 
773 1 8 |g volume:124  |g year:2017  |g number:11  |g pages:1579-1588  |g extent:10  |a Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy 
856 4 0 |u http://dx.doi.org/10.1016/j.ophtha.2017.05.004  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0161642017304645  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180511 
993 |a Article 
994 |a 2017 
998 |g 12088142X  |a Hengerer, Fritz  |m 12088142X:Hengerer, Fritz  |d 910000  |d 910900  |e 910000PH12088142X  |e 910900PH12088142X  |k 0/910000/  |k 1/910000/910900/  |p 8 
999 |a KXP-PPN1574984756  |e 3009148291 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Matthew B. Schlenker, Husayn Gulamhusein, Ina Conrad-Hengerer, Alix Somers, Markus Lenzhofer, Ingeborg Stalmans, Herbert Reitsamer, Fritz H. Hengerer, Iqbal Ike K. Ahmed"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"June 7, 2017"}],"id":{"eki":["1574984756"],"doi":["10.1016/j.ophtha.2017.05.004"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"id":{"eki":["320526941"],"zdb":["2015287-5"],"issn":["1549-4713"]},"origin":[{"dateIssuedKey":"1978","publisher":"Elsevier ; Acad.","dateIssuedDisp":"1978-","publisherPlace":"Amsterdam [u.a.] ; San Francisco, Calif."}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Ophthalmology","subtitle":"journal of the American Academy of Ophthalmology","title_sort":"Ophthalmology"}],"recId":"320526941","language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American Academy of Ophthalmology","role":"isb"}],"note":["Gesehen am 15.01.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomyOphthalmology","part":{"pages":"1579-1588","issue":"11","year":"2017","extent":"10","volume":"124","text":"124(2017), 11, Seite 1579-1588"},"pubHistory":["85.1978 -"]}],"person":[{"given":"Matthew","family":"Schlenker","role":"aut","display":"Schlenker, Matthew","roleDisplay":"VerfasserIn"},{"given":"Fritz","family":"Hengerer","role":"aut","display":"Hengerer, Fritz","roleDisplay":"VerfasserIn"}],"title":[{"title_sort":"Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy","title":"Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy"}],"note":["Gesehen am 11.05.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1574984756","language":["eng"]} 
SRT |a SCHLENKERMEFFICACYSA7201